Microsomal Triglyceride Transfer Protein Inhibitors [MoA] - N0000186778

Pharmacologic Class Information

Pharmacologic Code N0000186778
Pharmacologic Name Microsomal Triglyceride Transfer Protein Inhibitors
Pharmacologic Uses
  • microsomal triglyceride transfer protein inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Microsomal Triglyceride Transfer Protein Inhibitors

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Microsomal Triglyceride Transfer Protein Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
75929-027Juxtapid Non-Proprietary Name: Lomitapide MesylateCapsuleOralPharma Packaging Solutions, Llc Dba Tjoapack LlcACTIVE
75929-172Juxtapid Non-Proprietary Name: Lomitapide MesylateCapsuleOralPharma Packaging Solutions, Llc Dba Tjoapack LlcACTIVE
76431-105Juxtapid Non-Proprietary Name: Lomitapide MesylateCapsuleOralAmryt Pharmaceuticals DacACTIVE
76431-110Juxtapid Non-Proprietary Name: Lomitapide MesylateCapsuleOralAmryt Pharmaceuticals DacACTIVE
76431-120Juxtapid Non-Proprietary Name: Lomitapide MesylateCapsuleOralAmryt Pharmaceuticals DacACTIVE
76431-130Juxtapid Non-Proprietary Name: Lomitapide MesylateCapsuleOralAmryt Pharmaceuticals DacACTIVE